UK markets closed
  • NIKKEI 225

    27,518.25
    +41.38 (+0.15%)
     
  • HANG SENG

    19,784.65
    +216.96 (+1.11%)
     
  • CRUDE OIL

    73.13
    +0.32 (+0.44%)
     
  • GOLD FUTURES

    1,975.20
    +21.40 (+1.10%)
     
  • DOW

    32,319.37
    -112.71 (-0.35%)
     
  • Bitcoin GBP

    21,793.23
    -146.60 (-0.67%)
     
  • CMC Crypto 200

    588.87
    +346.19 (+142.66%)
     
  • NASDAQ Composite

    11,657.92
    -110.92 (-0.94%)
     
  • UK FTSE All Share

    4,072.46
    +1.39 (+0.03%)
     

Here is how city analysts rate Syncona

When it comes to researching shares, many investors take note of what city analysts have to say. The trading recommendations of these professionals are used by everyone from institutional fund managers to individual private investors. The reason is that these analysts know about the stocks they cover more than just about anybody else.

For investors, these kinds of recommendations can be a useful consideration - especially when you listen to the consensus view of all the analysts that cover a stock.

Take Syncona (LON:SYNC) as an example. Shares in the company have risen by 1.80% over the past month and they are currently trading at 170p. But what do the analysts that cover the company think?

Based on the broker 'consensus', there could be reasons to believe that the positive recent trend will continue. In terms of trading recommendations, Syncona currently has:

  • 2 Buy recommendations

  • 1 Hold recommendations

  • 0 Sell recommendations

This suggests that analysts are generally upbeat about the outlook.

At its current price of 170p, shares in Syncona are trading at a discount of -24.3% to its 52 week high price. The 1-year performance of the shares has been -23.6%.

While analyst forecasts can be a useful guide to what City 'experts' think about a stock's near term future, they can be unreliable. To get a better idea about the strengths and weaknesses of Syncona it's worth doing some investigation yourself. Indeed, we've identified some areas of concern with Syncona that you can find out about here.